Finance

Lists
ALHC:NASDAQ
Alignment Healthcare Inc
$13.52
-0.48%
(-0.065) 1D
Sep 3, 3:34:05 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALHC...
Open
$13.73
High
$13.83
Low
$13.30
Mkt. cap
2.81B
Avg. vol.
5.27M
Volume
2.71M
P/E ratio
72.45
52-wk high
$25.12
52-wk low
$12.70
EPS
$0.19
Beta
1.11
Shares outstanding
207.44M
No. of employees
2K
Open
$13.73
High
$13.83
Low
$13.30
Mkt. cap
2.81B
Avg. vol.
5.27M
Volume
2.71M
P/E ratio
72.45
52-wk high
$25.12
52-wk low
$12.70
EPS
$0.19
Beta
1.11
Shares outstanding
207.44M
No. of employees
2K
News stories
From web sources and news partners
About Alignment Healthcare Inc
CEOJohn Kao
Employees1.85K
Founded2013
HeadquartersOrange, California, United States
SectorHealth care provider
Websitealignmenthealth.com
Analyst ratings
Based on 9 analysts giving stock ratings to ALHC in the past 3 months
Strong buy
Buy
7
Hold
2
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for ALHC in the last 3 months.
Highest
Current $13.52
$28.00 (+107.02%)
Average
$21.86 (+61.63%)
Lowest
$16.00 (+18.30%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Stansel
J.P. Morgan
Buy
Maintained
$22.00
+62.7%
08/04/2026
Scott Fidel
Goldman Sachs
Buy
Maintained
$25.00
+84.8%
08/02/2026
Parker Snure
Raymond James
Buy
Maintained
$19.00
+40.5%
08/03/2026
Ryan Langston
TD Cowen
Buy
Reiterated
$21.00
+55.3%
08/03/2026
Gary Taylor
TD Cowen
Buy
Reiterated
$21.00
+55.3%
08/03/2026
Michael Craig Jones
Bank of America Securities
Buy
Maintained
-
-
07/31/2026
Andrew Mok CFA
Barclays
Hold
Maintained
$16.00
+18.3%
07/31/2026
Matthew Gillmor CFA
KeyBanc
Buy
Maintained
$28.00
+107%
07/31/2026
Ryan Daniels
William Blair
Buy
Reiterated
-
-
07/30/2026
John Ransom
Raymond James
Buy
Maintained
-
-
07/09/2026
Jonathan Yong
UBS
Hold
Maintained
$22.00
+62.7%
07/08/2026
Jessica Tassan
Piper Sandler
Buy
Reiterated
$30.00
+121.8%
03/02/2026
Michael Ha
Robert W. Baird
Buy
Maintained
$28.00
+107%
01/30/2026
Last report
Jul 30, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.25 / $0.20
+24.35%beat
Revenue / Est. (USD)
1.34B / 1.31B
+1.95%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
993.70M
1.01B
1.24B
1.34B
Cost of goods sold
868.02M
889.49M
1.09B
1.15B
Cost of revenue
868.02M
889.49M
1.09B
1.15B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
109.47M
126.46M
121.14M
131.00M
Operating expense
117.45M
134.32M
128.98M
138.86M
Total operating expenses
985.47M
1.02B
1.22B
1.29B
Operating income
8.23M
-11.01M
15.50M
42.10M
Other non operating income
-
-72.00K
-
1.00K
EBT including unusual items
3.73M
-14.23M
11.44M
37.83M
EBT excluding unusual items
4.28M
-15.03M
11.44M
37.83M
Income tax expense
2.00K
-3.23M
25.00K
1.27M
Effective tax rate
0.05%
22.67%
0.22%
3.35%
Other operating expenses
-
-
-
-
Net income
3.73M
-11.01M
11.42M
36.56M
Net profit margin
0.38%
-1.09%
0.92%
2.74%
Earnings per share
0.10
-0.00
0.12
0.25
Interest and investment income
-
-
-
-
Interest expense
-3.95M
-3.95M
-4.06M
-4.28M
Net interest expenses
-3.95M
-3.95M
-4.06M
-4.28M
Depreciation and amortization charges
7.98M
7.86M
7.84M
7.85M
EBITDA
16.21M
-3.18M
23.36M
49.96M
Gain or loss from assets sale
-
-
-
-1.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps